15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Goodrx Holdings Inc, 3 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $2.50 to $5.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $4.00 sits 14% above the current $3.52. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.08 next quarter toward $0.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy330%
Hold660%
Sell110%
Strong Sell00%
Based on 10 analysts giving stock ratings to Goodrx Holdings Inc.
As of Sep, 3 of 10 firms rate GDRX a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
GDRX EPS & revenue forecast
EPS · NEXT QUARTER
$0.08
Range $0.07 – $0.10 · 12 analysts · -11% YoY
Next period, 12 analysts expect Goodrx Holdings Inc to earn $0.08 a share (range $0.07 – $0.10), versus $0.09 a year earlier. Full-year consensus is $0.30, growing to $0.36 the year after.
REVENUE · NEXT QUARTER
$202.0M
Range $196.7M – $205.1M · 12 analysts · +4% YoY
Revenue is expected to reach $202.0M (range $196.7M – $205.1M), +3.7% year-over-year. Full-year consensus is $798.8M, rising to $840.1M next year.
Top analysts covering Goodrx Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GDRX.
#1
Brian Tanquilut
Jefferies · Rank #208
Hold
$2.75-21.9% to target
Overall win rate
42%
+ Follow
#2
Scott Schoenhaus
Keybanc · Rank #413
Buy
$6.00+70.5% to target
Overall win rate
30%
+ Follow
#3
Eric Sheridan
Goldman Sachs · Rank #415
Hold
$3.50-0.6% to target
Overall win rate
31%
+ Follow
#4
Daniel Grosslight
Citigroup
Buy
$5.00+42.0% to target
Coverage
—
+ Follow
#5
Stan Berenshteyn
Wells Fargo
Buy
$5.00+42.0% to target
Coverage
—
+ Follow
GDRX stock forecast FAQ
What is GDRX's average 12-month price target?+
The 9 analysts with a live target average $4.00 for Goodrx Holdings Inc over the next 12 months, ranging from a $5.00 high to a $2.50 low.
Is GDRX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 3 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for GDRX?+
The Street-high target is $5.00 (Citigroup), and the Street-low is $2.50 (Goldman Sachs). The average of all 9 active targets is $4.00.
How many Wall Street analysts cover GDRX?+
10 analysts have an active rating on Goodrx Holdings Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering GDRX?+
Among analysts who currently cover GDRX, Brian Tanquilut of Jefferies has the strongest overall Quantellect track record (Rank #208). Their current call is Hold with a $2.75 target.
What is Goodrx Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $0.08 per share (range $0.07 – $0.10) across 12 analysts. Full-year EPS is projected at $0.30, rising to $0.36 the following year.
How much revenue is Goodrx Holdings Inc expected to report next quarter?+
Consensus revenue is $202.0M (range $196.7M – $205.1M). Full-year revenue is projected at $798.8M, growing to $840.1M next year.
Have analysts been upgrading or downgrading GDRX lately?+
As of Sep, 3 of 10 firms rate GDRX a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GDRX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
